Alembic Pharma gets USFDA nod for generic cancer treatment injection:

Alembic Pharma gets USFDA nod for generic cancer treatment injection:

Daily Current Affairs   /   Alembic Pharma gets USFDA nod for generic cancer treatment injection:

Change Language English Hindi

Category : Science and Tech Published on: July 02 2025

Share on facebook

Alembic Pharmaceuticals has secured final approval from the USFDA for its generic Doxorubicin Hydrochloride Liposome injection (20 mg/10 mL and 50 mg/25 mL). This key oncology treatment approval under ANDA allows Alembic to market a cost-effective alternative for various cancers in the US.

Recent Post's

  • Sanjay Kaul takes charge as MD & CEO of GIFT City, India's premier financial hub.

    Read More....

  • NASA-ISRO joint satellite ‘NISAR’ to launch from Sriharikota on July 30.

    Read More....

  • Jio Financial and Allianz partner to launch 50:50 reinsurance venture in India.

    Read More....

  • Kotak Mahindra Prime becomes India’s first preferred financer for Tesla EVs.

    Read More....

  • Bihar leads with 12,817 new polling stations, capping 1,200 voters per booth.

    Read More....

  • FTII and Maharashtra Government sign MoU to expand media skill development.

    Read More....

  • India’s ‘Meri Panchayat’ app wins global WSIS Champion Award 2025.

    Read More....

  • Parliament clears ‘Bills of Lading, 2025’ to modernize shipping laws.

    Read More....

  • Deepak Bagla takes charge as the new Director of Atal Innovation Mission.

    Read More....

  • India to observe National Flag Day on July 22, honoring the Tiranga.

    Read More....

2025 © and Powered By Graposs Edutech Private Limited

Terms & Condition Privacy Policy Disclaimer